Sarepta Therapeutics traded lower on Monday, extending a slide as the company took the unusual step of refusing a Food and Drug Administration request to stop selling a drug tied to three deaths.
‘I have felt invisible, disrespected and heartbroken’: My firstborn son wants nothing to do with me. Do I cut him off?
“My second wife and I agreed that 25% of our total estate would go to my older son, and the remainder to our younger son.”
